The authors studied the clinical efficiency and safety of interferon alpha-2 (Reaferon-Es-Lipint) in oral dosing within complex therapy for acute respiratory viral infections. Dynamics of the main clinical and laboratory symptoms proves high efficiency of a medication and expediency of its use for the treatment of acute respiratory viral infections among children. Key words: children, acute respiratory viral infections, treatment, interferon alpha 2.